Objective masticatory efficiency and subjective quality of masticatory function among patients with periodontal disease DOI Creative Commons
Anna Greta Barbe,

Simin Javadian,

Thea Rott

и другие.

Journal Of Clinical Periodontology, Год журнала: 2020, Номер 47(11), С. 1344 - 1353

Опубликована: Сен. 6, 2020

To examine patient-centred clinical outcomes for objective masticatory efficiency (OME) and subjective quality of function (QMF) among periodontitis patients using test methods easily applicable in daily practice.Cross-sectional investigation undergoing supportive periodontal therapy (n = 224). Outcomes included OME QMF related to characteristics.OME were associated (x2 0.252, p 0.037) showed highest values stage 4 according the new classification disease. There correlations particularly 2 between number teeth -0.317, < 0.001), Quigley-Hein Index 0.152, 0.031), attachment level 0.268, probing depths 0.185, 0.006), tooth mobility 0.147, 0.031) functional occlusal units -0.423, 0.001) but not bleeding on probing. A trend existed -0.237, 0.050) 0.238, 0.058), other findings.OME represent each are 4. Periodontitis findings influence 2, gingival inflammation does not. Number with QMF, while have less impact. An assessment mastication should be routinely diagnosis all stages.

Язык: Английский

Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline DOI Creative Commons
Mariano Sanz, David Herrera, Moritz Kebschull

и другие.

Journal Of Clinical Periodontology, Год журнала: 2020, Номер 47(S22), С. 4 - 60

Опубликована: Май 8, 2020

The recently introduced 2017 World Workshop on the classification of periodontitis, incorporating stages and grades disease, aims to link disease with approaches prevention treatment, as it describes not only severity extent but also degree complexity an individual's risk. There is, therefore, a need for evidence-based clinical guidelines providing recommendations treat periodontitis.

Язык: Английский

Процитировано

1129

Treatment of stage IV periodontitis: The EFP S3 level clinical practice guideline DOI
David Herrera, Mariano Sanz, Moritz Kebschull

и другие.

Journal Of Clinical Periodontology, Год журнала: 2022, Номер 49(S24), С. 4 - 71

Опубликована: Июнь 1, 2022

Abstract Background The recently published clinical practice guideline (CPG) for the treatment of periodontitis in stages I–III provided evidence‐based recommendations patients, defined according to 2018 classification. Stage IV shares severity and complexity characteristics stage III periodontitis, but includes anatomical functional sequelae tooth periodontal attachment loss (tooth flaring drifting, bite collapse, etc.), which require additional interventions following completion active therapy. Aim To develop an S3 Level CPG focusing on implementation inter‐disciplinary approaches required treat/rehabilitate patients associated loss. Materials Methods This was developed by European Federation Periodontology (EFP), methodological guidance from Association Scientific Medical Societies Germany Grading Recommendations Assessment, Development Evaluation (GRADE) process. A rigorous transparent process included synthesis relevant research 13 specifically commissioned systematic reviews, evaluation quality strength evidence, formulation specific a structured consensus with leading experts broad base stakeholders. Results culminated different interventions, including orthodontic movement, splinting, occlusal adjustment, tooth‐ or implant‐supported fixed removable dental prostheses supportive care. Prior planning, it is critically important undertake definitive comprehensive diagnosis case evaluation, obtain patient information, engage frequent re‐evaluations during after treatment. component therapy should follow I–III. Conclusions present informs practice, health systems, policymakers and, indirectly, public available most effective modalities treat maintain healthy dentition over lifetime, evidence at time publication.

Язык: Английский

Процитировано

212

Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective DOI Creative Commons
Tord Berglundh, Andrea Mombelli, Frank Schwarz

и другие.

Periodontology 2000, Год журнала: 2024, Номер unknown

Опубликована: Фев. 2, 2024

Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It characterized by inflammation the peri‐implant mucosa and progressive loss of supporting bone. Over last 30 years, peri‐implantitis has become major disease burden dentistry. An understanding diagnosis, etiology pathogenesis, epidemiology, treatment must be central component undergraduate postgraduate training programs In view strong role European research periodontology implant dentistry, focus this review was to address from perspective. One work summarize new reliable data on patients with implants underpin relevance population The nature lesion evaluated through results presented preclinical models evaluations human biopsy material together an appraisal microbiological characteristics. overview strategies outcomes clinical studies nonsurgical surgical discussed particular end points therapy recommendations S3 level Clinical Practice Guideline for prevention diseases.

Язык: Английский

Процитировано

39

Effect of quadrantwise versus full‐mouth subgingival instrumentation on clinical and microbiological parameters in periodontitis patients: A randomized clinical trial DOI Creative Commons
Gaetano Isola, Alessandro Polizzi, Simona Santonocito

и другие.

Journal of Periodontal Research, Год журнала: 2024, Номер 59(4), С. 647 - 656

Опубликована: Апрель 26, 2024

Abstract Aim This study evaluated the efficacy of quadrantwise subgingival instrumentation (Q‐SI) versus one‐stage full‐mouth (FM‐SI) on probing depth and periodontal pathogen reduction over a 6‐month follow‐up period, as well whether baseline pathogens influenced impact treatment protocols outcomes. Methods Patients with periodontitis were randomized to receive Q‐SI ( n = 43) or FM‐SI 45). instructed motivated maintain optimal oral hygiene during sessions. Clinical (probing pocket [PPD], clinical attachment loss [CAL], bleeding [BOP]) assessed at after 30, 90, 180 days. Total bacterial load analysed via real‐time PCR. Results At follow‐up, median PPD decreased from 4.8 mm (interquartile range [IQR]: 4.3–5.2) 2.6 (IQR: 2.3–2.9) in patients 4.7 4.1–5.2) 3.2 2.4–3.5) p < .001). 6 months, was more effective reducing proportions Porphyromonas gingivalis Pg ), Aggregatibacter actinocomyctemcomitans , Tannerella forsythia Tf ) .001 for each value). Multilevel linear regression analysis demonstrated that high .029), .014), .001) levels protocol statistically significant predictors months. Furthermore, significantly greater group when lower detected. Conclusion The than mean number period. Higher had negative months FM‐SI.

Язык: Английский

Процитировано

37

Effects of minimally invasive non‐surgical therapy on C‐reactive protein, lipoprotein‐associated phospholipase A2, and clinical outcomes in periodontitis patients: A 1‐year randomized, controlled clinical trial DOI Creative Commons
Gaetano Isola, Paolo Pesce, Alessandro Polizzi

и другие.

Journal of Periodontology, Год журнала: 2024, Номер unknown

Опубликована: Май 2, 2024

Growing evidence suggests the type of periodontal treatment could differentially influence reduction key cardiovascular risk mediators in periodontitis patients. This randomized, controlled clinical trial compared impact minimally invasive non-surgical therapy (MINST) with quadrant-wise subgingival instrumentation (Q-SI) on C-reactive protein (CRP) together lipoprotein-associated phospholipase A

Язык: Английский

Процитировано

23

Periodontal Probing Depth Trajectory in 10 Years of Follow‐Up as Associated With Tooth Loss DOI Creative Commons
Peter Meisel, Henry Völzke, Thomas Kocher

и другие.

Journal Of Clinical Periodontology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 2, 2025

ABSTRACT Aim To elucidate whether ranked probing depth (PD) data translate into PD outcomes after 10 years of follow‐up and the associated tooth loss. Materials Methods From Study Health in Pomerania (SHIP‐START), all participants were retrospectively included with complete measurements both baseline 10‐year follow‐up, comprising 1887 participants. The trajectory percentile‐based quintiles mean was followed. Results Quintiles at were, a dose dependent manner, number teeth baseline, involved risk membership to individual indicated that majority remained or near their quintile reaching end analysis. Periodontal factors assessed continued affect follow‐up. Two categories loss identified: 1–2 lost versus ≥ 3 differentiated by PD. Conclusion severity within this population translates, dose‐dependent even many years. This underlines prospective importance pocket dental practice. Ranked offers simple measure identify patients high

Язык: Английский

Процитировано

2

BSP implementation of European S3 - level evidence-based treatment guidelines for stage I-III periodontitis in UK clinical practice DOI Creative Commons
Nicola West, Iain Chapple, N. Claydon

и другие.

Journal of Dentistry, Год журнала: 2021, Номер 106, С. 103562 - 103562

Опубликована: Фев. 9, 2021

To adapt the supranational European Federation for Periodontology (EFP) S3-Level Clinical Practice Guideline treatment of periodontitis (stage I-III) to a UK healthcare environment, taking into account views broad range stakeholders, and patients. This version is based on EFP guideline (Sanz et al., 2020) published in Journal Periodontology. The source was developed using S3-level methodology, which combined assessment formal evidence from 15 systematic reviews with moderated consensus process representative group accounts health equality, environmental factors clinical effectiveness. It encompasses 62 recommendations stage I–III periodontitis, step-wise mapped 2017 classification system. called GRADE ADOLOPMENT framework. framework allows adoption (unmodified acceptance), adaptation (acceptance modifications) de novo development recommendations. Using this following S3-process, underlying were updated 75 delegates 17 stakeholder organisations assembled three working groups. Following all formally assessed their applicability adoloped accordingly. protocol, practice developed. delivers evidence- consensus-based direct relevance dental community UK. aim guidelines combine evaluation evidence, grading synthesis expertise stakeholders form Herein, first major international dentistry, guideline, implemented

Язык: Английский

Процитировано

61

Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity DOI Creative Commons
Crystal Marruganti, Jean Suvan, Francesco D’Aiuto

и другие.

Periodontology 2000, Год журнала: 2023, Номер unknown

Опубликована: Окт. 16, 2023

Abstract Noncommunicable diseases (NCDs) are multifactorial, long‐term, chronic conditions that represent a burden to health‐care systems worldwide as they can only be controlled rather than cured; hence, require long‐term care. With the exponential increase in NCDs, occurrence of individuals presenting with more one disease is also rapidly rising. “Multimorbidity,” defined presence two or physical mental disorders, now considered epidemic, affecting around 20% adult population. Periodontitis, diabetes, and obesity, all inflammatory diseases, an example multimorbidity highly relevant dental practitioners. Over last three decades, three‐way relationship among has been vastly researched accepted, important contributions by European researchers. The interplay periodontitis, obesity sustained shared biological mechanisms, such systemic inflammation, insulin resistance, metabolic dysfunction, well common lifestyle‐related risk factors. As such, unhealthy lifestyles were found generally inflammation resistance decrease immune function, eventually increasing NCDs onset development multimorbidity. This narrative review evidence supports need for paradigm shift from “single‐disease” “multiple‐disease” framework, characterized integrated multidisciplinary approach, which should include lifestyle modification interventions successfully tackle multimorbid periodontitis (diabetes obesity). A care pathway both medical settings further global health challenge

Язык: Английский

Процитировано

42

Impact of N‐terminal pro‐B‐type natriuretic peptide and related inflammatory biomarkers on periodontal treatment outcomes in patients with periodontitis: An explorative human randomized‐controlled clinical trial DOI Creative Commons
Gaetano Isola, Gianluca Martino Tartaglia, Simona Santonocito

и другие.

Journal of Periodontology, Год журнала: 2023, Номер 94(12), С. 1414 - 1424

Опубликована: Июль 11, 2023

N-terminal portion of the B-type natriuretic propeptide (NT-proBNP) has potentially been shown to play an important role in development periodontitis and cardiovascular disease (CVD). This study evaluated efficacy periodontal treatment on NT-proBNP related CVD biomarkers explored whether subjects harboring high at baseline showed increased clinical benefits with non-surgical performed full-mouth scaling root planing (FM-SRP) 6-month follow-up.

Язык: Английский

Процитировано

33

Patient‐Reported Outcomes Following Systemic Antibiotic Adjunct to Nonsurgical Treatment of Periodontitis: A Randomized Controlled Clinical Trial DOI Creative Commons

Parastoo Parhizkar,

Jaber Yaghini, Omid Fakheran

и другие.

Clinical and Experimental Dental Research, Год журнала: 2025, Номер 11(1)

Опубликована: Янв. 13, 2025

Considering the importance of patient-centered care, we aimed to evaluate impact systemic antibiotics on oral health-related quality life during nonsurgical periodontal treatment. This controlled trial addresses a gap in understanding how influence patient-reported outcomes, focusing Stage III periodontitis. Sixty-one adults participated double-blind, randomized clinical trial, with participants divided into two groups: test group, which received antibiotics, and control group. All We conducted follow-up assessments at one 3 months posttreatment, including recording parameters administering Oral Health Impact Profile-14 (OHIP-14) questionnaire. The results showed notable improvement for patients group compared 1 month (p value = 0.012) 0.014) after While there were improvements pocket probing depth, gingival index, attachment loss both groups, it is worth noting that only bleeding exhibited significant 0.008). In summary, incorporating alongside treatments appears bring about positive outcomes individuals dealing periodontitis treatment, ultimately enhancing their life. Iranian Registry Clinical Trials (IRCT Id): IRCT20201221049786N1.

Язык: Английский

Процитировано

1